An activated aberrant PI3K/protein kinase B (AKT)/mTOR signaling pathway results in a more aggressive tumor phenotype with enhanced angiogenesis, proliferation, metastases, and drug resistance [10, 11]. This evidence concerns the gene PIK3CA and neoplasm.